Smith Anglin Financial »

Amneal Pharmaceuticals shares owned by Smith Anglin Financial

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by Smith Anglin Financial from 13F filings

Historical chart of Smith Anglin Financial investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by Smith Anglin Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by Smith Anglin Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $176k 29k 6.06
2023-12-31 $176k 29k 6.07
2023-09-30 $122k 29k 4.22
2023-06-30 $90k 29k 3.10
2023-03-31 $42k 30k 1.39

More positions owned by Smith Anglin Financial

Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Core S&p500 Etf (IVV)
John Hancock Exchange Traded Multifactor Mi (JHMM)
Cambria Etf Tr Shshld Yield Etf (SYLD)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Ishares Tr 10-20 Yr Trs Etf (TLH)
Ishares Tr S&p 500 Val Etf (IVE)
American Centy Etf Tr Us Eqt Etf (AVUS)
Cambria Etf Tr Emrg Sharehldr (EYLD)
Ishares Tr Core Div Grwth (DGRO)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Vanguard Specialized Funds Div App Etf (VIG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)

View all positions for Smith Anglin Financial

Top funds holding Amneal Pharmaceuticals

Fosun International
Vanguard Group
Tpg Gp A
Citadel Advisors
Neuberger Berman Group
Dimensional Fund Advisors
Nantahala Capital Management
Charles Schwab Investment Management
LSV Asset Management
AQR Capital Management
Teacher Retirement System Of Texas
Phocas Financial
D. E. Shaw & Co
Russell Investments
Bank of New York Mellon

View all funds holding Amneal Pharmaceuticals